Traditional STS research has primarily focused on identifying recurrent gene mutations, characterizing oncogenic signaling pathways such as PI3K/AKT/mTOR and RAS/MAPK, and exploring immune checkpoint expression and tumor-infiltrating lymphocytes (14, 15). This evidence concerns the gene AKT1 and neoplasm.